Fludarabine Phosphate Injection
Product Name: Fludarabine Phosphate Injection
Common Name: Fludarabine Phosphate
Strength: 50 mg/6 ml vial
Description:
Fludarabine Phosphate Injection is an antineoplastic agent used in the treatment of certain types of blood cancers. It belongs to the class of drugs known as purine analogs, which work by inhibiting DNA synthesis, thereby preventing the growth and multiplication of cancer cells. Fludarabine is commonly used in the treatment of chronic lymphocytic leukemia (CLL), non-Hodgkin’s lymphoma, and other lymphoid malignancies. It is typically administered via intravenous infusion.
Fludarabine is cytotoxic to cancer cells, interfering with their DNA repair processes and leading to apoptosis (cell death). This makes it an effective option for treating cancers that involve rapid cellular proliferation.
Indications and Usage:
Fludarabine Phosphate Injection is indicated for:
- Treatment of adult patients with chronic lymphocytic leukemia (CLL) who have not responded to other treatment modalities.
- Treatment of indolent non-Hodgkin’s lymphoma.
- Treatment of relapsed or refractory leukemia and lymphomas.
- Off-label use in certain autoimmune disorders and other hematologic malignancies.
Features:
- Potent antineoplastic agent targeting lymphoid cancers.
- Effective in cases of relapsed or refractory chronic lymphocytic leukemia.
- Administered via intravenous infusion for optimal absorption.
- May be used alone or in combination with other chemotherapy agents.
- Offers cytotoxic effects by interfering with DNA synthesis and repair.
Pack Size: Fludarabine Phosphate Injection is available in 6ml vial.
Minimum Order Quantity: 3000 packs
Certification: WHO-GMP
